COLL vs CUBE
Collegium Pharmaceutical Inc (COLL) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the COLL and CUBE stock pages for the full models.
Not investment advice.